David W. Stepp

6.0k total citations
106 papers, 4.7k citations indexed

About

David W. Stepp is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, David W. Stepp has authored 106 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Physiology, 36 papers in Cardiology and Cardiovascular Medicine and 29 papers in Molecular Biology. Recurrent topics in David W. Stepp's work include Nitric Oxide and Endothelin Effects (31 papers), Adipose Tissue and Metabolism (14 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). David W. Stepp is often cited by papers focused on Nitric Oxide and Endothelin Effects (31 papers), Adipose Tissue and Metabolism (14 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). David W. Stepp collaborates with scholars based in United States, China and Canada. David W. Stepp's co-authors include David Fulton, Jefferson C. Frisbee, William M. Chilian, Yasuhiro Nishikawa, James Mintz, Feng Chen, R. Daniel Rudic, Eric J. Belin de Chantemèle, David M. Pollock and Ciprian B. Anea and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David W. Stepp

105 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Stepp United States 41 2.0k 1.3k 1.3k 667 616 106 4.7k
Lin Chang United States 37 1.6k 0.8× 1.2k 1.0× 1.4k 1.1× 551 0.8× 483 0.8× 98 5.0k
Axel Gödecke Germany 40 2.4k 1.2× 2.4k 1.9× 1.5k 1.2× 357 0.5× 320 0.5× 95 5.9k
Zsolt Bagi United States 38 1.8k 0.9× 1.3k 1.0× 1.2k 1.0× 238 0.4× 391 0.6× 118 4.7k
William G. Mayhan United States 47 2.6k 1.3× 1.3k 1.0× 1.9k 1.5× 640 1.0× 309 0.5× 172 6.6k
Gregory D. Fink United States 43 1.9k 0.9× 1.2k 0.9× 2.7k 2.2× 721 1.1× 250 0.4× 181 5.7k
Pawel M. Kaminski United States 35 2.4k 1.2× 1.5k 1.2× 1.3k 1.0× 206 0.3× 682 1.1× 68 4.9k
Gillian A. Gray United Kingdom 38 2.9k 1.5× 1.4k 1.1× 2.2k 1.7× 252 0.4× 435 0.7× 131 5.5k
Tomio Okamura Japan 33 2.1k 1.1× 781 0.6× 1.2k 0.9× 459 0.7× 182 0.3× 167 4.1k
Hai‐Jian Sun China 39 873 0.4× 2.1k 1.7× 781 0.6× 301 0.5× 579 0.9× 155 5.3k
Jo G. R. De Mey Netherlands 39 2.5k 1.2× 1.8k 1.4× 2.0k 1.6× 289 0.4× 300 0.5× 172 5.9k

Countries citing papers authored by David W. Stepp

Since Specialization
Citations

This map shows the geographic impact of David W. Stepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Stepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Stepp more than expected).

Fields of papers citing papers by David W. Stepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Stepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Stepp. The network helps show where David W. Stepp may publish in the future.

Co-authorship network of co-authors of David W. Stepp

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Stepp. A scholar is included among the top collaborators of David W. Stepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Stepp. David W. Stepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bordán, Zsuzsanna, Yuqing Huo, Feng Chen, et al.. (2025). PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity. Antioxidants. 14(2). 172–172.
2.
Bruder‐Nascimento, Thiago, David W. Stepp, Rodger D. MacArthur, et al.. (2025). CD4 + T Cells Expressing Viral Proteins Induce HIV-Associated Endothelial Dysfunction and Hypertension Through Interleukin 1α–Mediated Increases in Endothelial NADPH Oxidase 1. Circulation. 151(16). 1187–1203. 5 indexed citations
3.
Larion, Sebastian, James Mintz, Jennifer Thompson, et al.. (2024). NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass. American Journal of Physiology-Gastrointestinal and Liver Physiology. 326(3). G264–G273. 3 indexed citations
4.
Bordán, Zsuzsanna, Stephen Haigh, Xueyi Li, et al.. (2024). PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension. Circulation. 150(5). 393–410. 5 indexed citations
5.
Haigh, Stephen, James Mintz, Ryan A. Harris, et al.. (2023). Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1. Arteriosclerosis Thrombosis and Vascular Biology. 43(10). e381–e395. 10 indexed citations
6.
Mintz, James, Stephen Haigh, Jeremy Sword, et al.. (2023). Early Endothelial Dysfunction in a Novel Model of Sustained Hyperphagia and Obesity in Mice Using a Brain Targeting Adeno-Associated Virus. Arteriosclerosis Thrombosis and Vascular Biology. 43(8). 1592–1594. 3 indexed citations
8.
Larion, Sebastian, et al.. (2022). The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(4). G387–G400. 19 indexed citations
9.
Rodriguez‐Miguelez, Paula, Jinhee Jeong, Jeffrey Thomas, et al.. (2022). Endothelin‐1 response to whole‐body vibration in obese and normal weight individuals. Physiological Reports. 10(10). e15335–e15335. 4 indexed citations
10.
Cusworth, Daniel, Andrew K. Thorpe, Alana Ayasse, et al.. (2022). Strong methane point sources contribute a disproportionate fraction of total emissions across multiple basins in the United States. Proceedings of the National Academy of Sciences. 119(38). e2202338119–e2202338119. 67 indexed citations
11.
Guha, Avirup, Xiaoling Wang, Ryan A. Harris, et al.. (2021). Obesity and the Bidirectional Risk of Cancer and Cardiovascular Diseases in African Americans: Disparity vs. Ancestry. Frontiers in Cardiovascular Medicine. 8. 761488–761488. 14 indexed citations
12.
Benson, Tyler W., Neal L. Weintraub, Ha Won Kim, et al.. (2018). A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome. Laboratory Investigation. 98(10). 1300–1310. 22 indexed citations
13.
Mohamed, Riyaz, Calpurnia Jayakumar, Feng Chen, et al.. (2015). Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. Journal of the American Society of Nephrology. 27(3). 745–765. 101 indexed citations
14.
Chantemèle, Eric J. Belin de, M. Irfan Ali, James Mintz, et al.. (2012). Increasing Peripheral Insulin Sensitivity by Protein Tyrosine Phosphatase 1B Deletion Improves Control of Blood Pressure in Obesity. Hypertension. 60(5). 1273–1279. 22 indexed citations
15.
Chantemèle, Eric J. Belin de, James Mintz, William E. Rainey, & David W. Stepp. (2011). Impact of Leptin-Mediated Sympatho-Activation on Cardiovascular Function in Obese Mice. Hypertension. 58(2). 271–279. 82 indexed citations
16.
Romero, Maritza J., Jennifer A. Iddings, Daniel Platt, et al.. (2011). Diabetes-induced vascular dysfunction involves arginase I. American Journal of Physiology-Heart and Circulatory Physiology. 302(1). H159–H166. 74 indexed citations
17.
Ketsawatsomkron, Pimonrat, David W. Stepp, David Fulton, & Mario B. Marrero. (2010). Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: Roles of Protein Tyrosine Phosphatase-1B. Vascular Pharmacology. 53(3-4). 160–168. 11 indexed citations
18.
Quigley, Jeffrey E., Ahmed A. Elmarakby, Sarah Knight, et al.. (2009). OBESITY INDUCED RENAL OXIDATIVE STRESS CONTRIBUTES TO RENAL INJURY IN SALT‐SENSITIVE HYPERTENSION. Clinical and Experimental Pharmacology and Physiology. 36(7). 724–728. 23 indexed citations
19.
Prakash, Rajan, James Mintz, & David W. Stepp. (2006). Impact of Obesity on Coronary Microvascular Function in the Zucker Rat. Microcirculation. 13(5). 389–396. 24 indexed citations
20.
Stepp, David W., et al.. (2005). Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. American Journal of Physiology-Heart and Circulatory Physiology. 289(5). H2097–H2102. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026